Faculty profile

Francis Rodier

ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Francis Rodier

Researcher

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
12 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (3 CIHR, 1 NSERC), most recently in 2022.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cell Cycle Cell Death Cell Senescence Chemotherapy Dna Damage High-Content Imaging Patient Derived Xenograft Primary Cultures-Cells/Organs

Latest papers

Development and validation of HPLC-UV and HPLC-MS/MS methods for ML-210 quantification.
Talanta · 2026
Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma.
BMC cancer · 2026
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma.
Cell reports · 2025

All 36 publications

Latest funding

Probing senescence in ovarian cancer treatment resistance: a story through time and space
CIHR · 2024 · Supervisor
$120,000
Targeting interleukin-22 through dietary supplementation to control gut inflammation, tumorigenesis, and microbiota homeostasis
CIHR · 2024 · Co-investigator
$696,150
P21 regulation in senescent ovarian cancer cell
CIHR · 2023 · Supervisor
$1,500

All 9 grants and awards

36 publications.

Development and validation of HPLC-UV and HPLC-MS/MS methods for ML-210 quantification.

Murphy M, Mahrouche L, Jutras M, Friciu M, Rodier F, Ferbeyre G, Yu F, Roullin VG, Leclair G

Talanta2026

DOI: 10.1016/j.talanta.2026.130422 PMID: 42594441

Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma.

Cardin GB, Pellerin-Viger A, Bernard M, Kessai F, Ayad T, Bissada E, Guertin L, Tabet P, Gologan OE, Filion E, Nguyen-Tan PF, Desilets A, Cheng AP, Rodier F, Bahig H, Christopoulos A

BMC cancer2026

DOI: 10.1186/s12885-026-16342-2 PMID: 42277742

The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma.

Berry D, Moldoveanu D, Rajkumar S, Lajoie M, Lin T, Tchelougou D, Sakthivel S, Sharon I, Bernard A, Pelletier S, Ripstein Y, Spatz A, Miller WH, Jamal R, Lapointe R, Mes-Masson AM, Petrecca K, Meguerditchian AN, Richardson K, Wang B, Chergui M, Guiot MC, Watters K, Stagg J, Schmeing TM, Rodier F, Turcotte S, Mihalcioiu C, Meterissian S, Watson IR

Cell reports2025

DOI: 10.1016/j.celrep.2025.115365 PMID: 40023845

SMARCA4 regulates the NK-mediated killing of senescent cells.

Reen V, D'Ambrosio M, Søgaard PP, Tyson K, Leeke BJ, Clément I, Dye ICA, Pombo J, Kuba A, Lan Y, Burr J, Bomann IC, Kalyva M, Birch J, Khadayate S, Young G, Provencher D, Mes-Masson AM, Vernia S, McGranahan N, Brady HJM, Rodier F, Nativio R, Percharde M, McNeish IA, Gil J

Science advances2025

DOI: 10.1126/sciadv.adn2811 PMID: 39813356

Guidelines for minimal information on cellular senescence experimentation in vivo.

Ogrodnik M, Carlos Acosta J, Adams PD, d'Adda di Fagagna F, Baker DJ, Bishop CL, Chandra T, Collado M, Gil J, Gorgoulis V, Gruber F, Hara E, Jansen-Dürr P, Jurk D, Khosla S, Kirkland JL, Krizhanovsky V, Minamino T, Niedernhofer LJ, Passos JF, Ring NAR, Redl H, Robbins PD, Rodier F, Scharffetter-Kochanek K, Sedivy JM, Sikora E, Witwer K, von Zglinicki T, Yun MH, Grillari J, Demaria M

Cell2024

DOI: 10.1016/j.cell.2024.05.059 PMID: 39121846

Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells.

Tchelougou D, Malaquin N, Cardin GB, Desmul J, Turcotte S, Rodier F

Frontiers in cell and developmental biology2024Senior author

DOI: 10.3389/fcell.2024.1368711 PMID: 38946802

Premature thymic functional senescence is a hallmark of childhood acute lymphoblastic leukemia survivorship.

Kientega T, Marcoux S, Bourbonnais J, Montpetit J, Caru M, Cardin GB, Arbour N, Marcil V, Curnier D, Laverdière C, Sinnett D, Rodier F

Blood cancer journal2024Senior author

DOI: 10.1038/s41408-024-01071-1 PMID: 38871704

Author Correction: Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence.

Fleury H, Malaquin N, Tu V, Gilbert S, Martinez A, Olivier MA, Sauriol SA, Communal L, Leclerc-Desaulniers K, Carmona E, Provencher D, Mes-Masson AM, Rodier F

Nature communications2024Senior author

DOI: 10.1038/s41467-024-48270-9 PMID: 38740764

Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).

Malaquin N, Rodier F

Methods in cell biology2024Senior author

DOI: 10.1016/bs.mcb.2022.10.005 PMID: 38302239

Radiotherapy on-chip: microfluidics for translational radiation oncology.

Chermat R, Ziaee M, Mak DY, Refet-Mollof E, Rodier F, Wong P, Carrier JF, Kamio Y, Gervais T

Lab on a chip2022

DOI: 10.1039/d2lc00177b PMID: 35477748

Probing senescence in ovarian cancer treatment resistance: a story through time and space

SupervisorCIHR2024Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Montpetit, Jade

Keywords: Biomarker Discovery; Organoids; Ovarian Cancer; Patient-Derived Xenografts (Pdx); Personnalized Medecine; Preclinical Models; Rna Sequencing; Senescence; Spatio-Temporal Analysis; Treatment Resistance

$120,000

Targeting interleukin-22 through dietary supplementation to control gut inflammation, tumorigenesis, and microbiota homeostasis

Co-investigatorCIHR2024Project Grant

Principal investigators: Santos, Manuela M

Keywords: Acetate; Colorectal Cancer; Il-22; Inflammation; Microbiota; Postbiotics; Probiotics; Putrescine

$696,150

P21 regulation in senescent ovarian cancer cell

SupervisorCIHR2023Travel Awards - Institute Community Support

Principal investigators: Goy, Erwan

Keywords: Bourses De Voyage D'Aci

$1,500

Probing senescence using ovarian cancer treatment response patient avatars

SupervisorCIHR2023Travel Awards - Institute Community Support

Principal investigators: Montpetit, Jade

Keywords: Cancer De L'Ovaire; Modèles Personnalisés; Sénescence; Traitement

$850

Inflammatory phenotype, senescence, and viscoelasticity imaging of macrophages in HIV

Co-investigatorCIHR2023Project Grant

Principal investigators: Cloutier, Guy

Keywords: Acoustic Shear Wave Analysis; Cell Elasticity; Cell Viscosity; Early Atherosclerosis; Imaging Of Cell Biomechanics; Immune System Senescence; Macrophage Engulfing; Macrophages; People Living With Hiv; Premature Aging

$726,750

Dissection of non-canonical DNA damage response mechanisms controlling the senescence program

Principal investigatorNSERC2022Discovery Grants Program - Individual

Principal investigators: Rodier, Francis

$102,000

Probing molecular mechanisms of epithelial ovarian cancer therapy-induced senescence to find biomarkers and drug targets

Nominated PICIHR2020Project Grant

Principal investigators: Rodier, Francis

Keywords: Cell Cycle; Cell Death; Cell Senescence; Chemotherapy; Dna Damage; High-Content Imaging; Patient Derived Xenograft; Primary Cultures-Cells/Organs; Therapy-Induced Cellular Senescence; Tissue Microarrays

$1,021,276

Mechanisms regulating persistent DNA damage signaling and the linked control of cell proliferation and extracellular signals

Nominated PICIHR2011Operating Grant

Principal investigators: Rodier, Francis

Keywords: Cell Cycle Checkpoints; Cytokine Secretion; Dna Damage Response Recovery; Dna Damage Response Signaling; Enzyme-Mediated Dna Breaks; High-Content Imaging; Medium-Throughput Measurements; Persistent Dna Damage Signaling; Primary Human Cell Culture; Telomere Dysfunction

$606,634

Evaluation of the Reprogramming Consequences of the Senescence-Associated Secretory Phenotype on Macrophage and Their Role in Senescent Cell Clearance

Principal investigatorCIHR2010Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging

Principal investigators: Cailhier, Jean-Francois; Rodier, Francis

Keywords: Age-Associated Diseases; Inflammation; Macrophage Biology; Macrophage Reprogramming; Phagocytosis Of Apoptotic And Senescent Cells; Senescence-Associated Secretory Phenotype; Senescent Cells Clearance

$50,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Francis Rodier

Research

Latest papers

Latest funding

Development and validation of HPLC-UV and HPLC-MS/MS methods for ML-210 quantification.

Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma.

The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanoma.

SMARCA4 regulates the NK-mediated killing of senescent cells.

Guidelines for minimal information on cellular senescence experimentation in&#xa0;vivo.

Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells.

Premature thymic functional senescence is a hallmark of childhood acute lymphoblastic leukemia survivorship.

Author Correction: Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence.

Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).

Radiotherapy on-chip: microfluidics for translational radiation oncology.

Dissection of non-canonical DNA damage response mechanisms controlling the senescence program

Frequent collaborators

Anne-Marie Mes-Masson

Houda Bahig

Philip Wong

Daniel Sinnett

Gerardo Ferbeyre

Sarkis Meterissian

Emile Levy

Claude Perreault

Catalin Mihalcioiu

Gerardo Ferbeyre

Chantal Autexier

Kevin Petrecca

Nathalie Perreault

Lambert Busque

Jean Roy

Sandra Cohen

Guy Sauvageau

Nathalie Rivard

Denis-Claude Roy

Gilbert Bernier

Reggie Hamdy

Kevin Petrecca

Guidelines for minimal information on cellular senescence experimentation in vivo.